Abstract:In this work, Surface-enhanced Raman spectroscopy (SERS) involving blood plasma was investigated; the objective was to determine whether this approach could distinguish prostate cancer with benign prostatic hyperplasia. The experimental samples were prepared by blood plasma mixed with the silver colloid over an aluminum plate substrate. A total of 14 SERS spectra for prostate cancer (PCa) and 14 spectra for benign prostatic hyperplasia (BPH) were successfully gathered from patients who came from Fujian Provincial Hospital. Difference spectrum analysis combined with the assignment of Raman bands indicated that there were subtle but distinct changes between prostate cancer (PCa) and benign prostatic hyperplasia (BPH), which could be related to the level of prostate specific antigen (PSA); because it has been reported that the level of PSA is increased in men who have prostate cancer compared with those with benign prostatic hyperplasia (BPH). To further make clear the difference of Prostate cancer (PCa) and benign prostatic hyperplasia (BPH), the spectral data was combined with multivariate analysis processes. Principal component analysis (PCA), as a spectral dimensionality reduction approach, and in conjunction with linear discriminant analysis (LDA) were employed to identify the samples, to build diagnostic algorithms. The leave-one-out cross-validation method was used to validate the diagnostic algorithms; the result showed that a sensitivity of 95.8% and a specificity of 100.0% which indicated can significantly differentiate PCa and BPH groups. In addition, we further verify the validity of the diagnosis algorithm based on PCA-LDA diagnosis algorithm by using receiver operating characteristic (ROC) curves. The results of experiment study suggest that SERS combined with PCA-LDA algorithms has great potential for clinical screening of benign prostate hyperplasia and prostate cancer.

A SERS-LFA biosensor combined with aptamer recognition for simultaneous detection of thrombin and PDGF-BB in prostate cancer plasma

Electrophoresis-Enhanced Localized Surface Plasmon Resonance Sensing Based on Nanocup Array for Thrombin Detection

SERS-based biosensor for detection of f-PSA%: Implications for the diagnosis of prostate cancer

Multifunctional nanocone array as solid immunoassay plate and SERS substrate for the early diagnosis of prostate cancer on microfluidic chip

Portable SERS-based lateral flow immunoassay strips with self-calibration for detection of a prostate cancer biomarker

Surface plasmon resonance biosensor using hydrogel-AuNP supramolecular spheres for determination of prostate cancer-derived exosomes

Simultaneous noninvasive ultrasensitive detection of prostate specific antigen and lncRNA PCA3 using multiplexed dual optical microfibers with strong plasmonic nanointerfaces

Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins

A label-free fluorescent aptasensor based on HCR and G-quadruplex DNAzymes for the detection of prostate-specific antigen

Label-free detection of prostate cancer and benign prostatic hyperplasia based on SERS spectroscopy of Plasma

A highly sensitive ratiometric electrochemical aptasensor for prostate specific antigen detection based on toehold-mediated strand displacement reaction

Enzyme-guided plasmonic biosensor based on dual-functional nanohybrid for sensitive detection of thrombin.

Gold nanoprism enhanced SERS aptasensor for simultaneous detection of thrombin and VEGF

Optical Microfiber Coated with WS2‐Supported Gold Nanobipyramids: Ultrasensitive Detecting Prostate Cancer Extracellular Vesicles in Complex Human Samples

Plasmonic internal standard-decorated nitrocellulose membranes for duplex detection of circulating tumor biomarkers

Aptamer-Based Functionalized SERS Biosensor for Rapid and Ultrasensitive Detection of Gastric Cancer-Related Biomarkers

Target-aptamer binding triggered isothermal strand displacement polymerase reaction for prostate specific antigen detection

A SPR biosensor based on signal amplification using antibody-QD conjugates for quantitative determination of multiple tumor markers

Ultrasensitive Detection of Prostate-Specific Antigen Using a SERS-Based Magnetic Immunosensor

Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.

SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers